Menopausal Hormone Therapy (MHT) discontinuation and shortages October 2024
Australia
Patch Shortages
There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia. Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.
Oestradiol patches
|
Expected supply due |
Alternative supply under Section 19A |
|||
|
Dose |
Estradot |
Estraderm |
Estramon |
Estradiol Transdermal System |
|
25 mcg |
20 Jan 2025 |
24 Nov 2024 |
Available |
|
|
37.5 mcg |
20 Jan 2025 |
Available |
20 Jan 2025 |
|
|
50 mcg |
20 Jan 2025 |
24 Nov 2024 |
Available |
20 Jan 2025 |
|
75 mcg |
20 Jan 2025 |
11 Nov 2024 |
Available |
20 Jan 2025 |
|
100 mcg |
20 Jan 2025 |
25 Nov 2024 |
Available |
20 Jan 2025 |
Combined patches
|
Dose |
Estalis Sequi |
Estalis Conti |
|
50/140 |
Available |
Available |
|
50/250 |
Available |
28th Nov 2024 |
All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.
The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.
New Zealand
As at 28th October 2024, patch availability is provided below.
|
Dose |
Estradot |
Viatris |
Estraderm MX |
|
25mcg |
Low |
Available |
Available |
|
50mcg |
Low |
Available |
|
|
75mcg |
Low |
Available |
|
|
100mcg |
Low |
Available |
More information can be found here
The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.